Q&A on diagnosis, screening and follow-up of colorectal neoplasia

Digestive and Liver Disease

Volumn 40, Issue 2, 2008, Pages 85-96

  Hassan, C ^a   Laghi, A ^b   Zullo, A ^a   Iafrate, F ^b   Morini, S ^a  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b University Polo Pontino   (Italy)

Author keywords

Colorectal cancer; Colorectal neoplasia; Endoscopy; Epidemiology; Screening; Virtual colonoscopy

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

ADENOMATOUS POLYP; AGE DISTRIBUTION; ARTICLE; BARIUM ENEMA; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL TUMOR; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC ECHOGRAPHY; FAMILY HISTORY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; METHODOLOGY; OCCULT BLOOD TEST; POLYPECTOMY; PREVALENCE; RISK REDUCTION; SEX DIFFERENCE; SIGMOIDOSCOPY; SURVIVAL RATE; SURVIVAL TIME;

BARIUM SULFATE; BIOLOGICAL MARKERS; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLORECTAL NEOPLASMS; ENEMA; HUMANS; MASS SCREENING; OCCULT BLOOD; RISK FACTORS; SIGMOIDOSCOPY;

EID: 38049051164     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.09.007     Document Type: Article

References (99)

1. Boyle P., and Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 16 (2005) 481-488
2. Malila N., and Hakulinen T. Epidemiological trends of colorectal cancer in the Nordic countries. Scand J Surg 92 (2003) 5-9
3. Scheiden R., Pescatore P., Wagener Y., Kieffer N., and Capesius C. Colon cancer in Luxembourg: a national population-based data report, 1988-1998. BMC Cancer 5 (2005) 52
4. Crocetti E., Capocaccia R., Casella C., Guzzinati S., Ferretti S., Rosso S., et al. Population-based incidence and mortality cancer trends (1986-1997) from the network of Italian cancer registries. Eur J Cancer Prev 13 (2004) 287-295
5. Minami Y., Nishino Y., Tsubono Y., Tsuji I., and Hisamichi S. Increase of colon and rectal cancer incidence rates in Japan: trends in incidence rates in Miyagi Prefecture, 1959-1997. J Epidemiol 16 (2006) 240-248
6. Levi F., Lucchini F., Negri E., Zatonski W., Boyle P., and La Vecchia C. Trends in cancer mortality in the European Union and accession countries, 1980-2000. Ann Oncol 15 (2004) 1425-1431
7. Goh K.L., Quek K.F., Yeo G.T., Hilmi I.N., Lee C.K., Hasnida N., et al. Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther 22 (2005) 859-864
8. Ries L.A., Wingo P.A., Miller D.S., Howe H.L., Weir H.K., Rosenberg H.M., et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88 (2000) 2398-2424
9. Weir H.K., Thun M.J., Hankey B.F., Ries L.A., Howe H.L., Wingo P.A., et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95 (2003) 1276-1299
10. Quinn M.J. Cancer trends in the United States-a view from Europe. J Natl Cancer Inst 95 (2003) 1258-1261
11. Sant M., Aareleid T., Berrino F., Bielska Lasota M., Carli P.M., Faivre J., Grosclaude P., et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 14 (2003) v61-v118
12. Brenner H., Stegmaier C., and Ziegler H. Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium. Ann Oncol 16 (2005) 981-986
13. Faivre-Finn C., Bouvier-Benhamiche A.M., Phelip J.M., Manfredi S., Dancourt V., and Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut 51 (2002) 60-64
14. Sonnenberg A., Delco F., and Inadomi J.M. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133 (2000) 573-584
15. Ladabaum U., and Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology 129 (2005) 1151-1162
16. Hassan C, Zullo A, Laghi A, Reitano I, Taggi F, Cerro P, et al. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy. Dig Liver Dis 2006;PMID:17112797.
17. http://seer.cancer.gov
18. Imperiale T.F., Wagner D.R., Lin C.Y., Larkin G.N., Rogge J.D., and Ransohoff D.F. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 346 (2002) 1781-1785
19. Mitchell R.J., Campbell H., Farrington S.M., Brewster D.H., Porteous M.E., and Dunlop M.G. Prevalence of family history of colorectal cancer in the general population. Br J Surg 92 (2005) 1161-1164
20. Johns L.E., and Houlston R.S. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 96 (2001) 2992-3003
21. Burt R.W. Familial risk and colorectal cancer. Gastroenterol Clin N Am 25 (1996) 793-803
22. Lynch H.T., and de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 348 (2003) 919-932
23. Regula J., Rupinski M., Kraszewska E., Polkowski M., Pachlewski J., Orlowska J., et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 355 (2006) 1863-1872
24. Chen C.D., Yen M.F., Wang W.M., et al. A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. Br J Cancer 88 (2003) 1866-1873
25. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329 (1993) 1977-1981
26. Citarda F., Tomaselli G., Capocaccia R., Barcherini S., Crespi M., and Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 48 (2001) 812-815
27. Stryker S.J., Wolff B.G., Culp C.E., Libbe S.D., Ilstrup D.M., and MacCarty R.L. Natural history of untreated colonic polyps. Gastroenterology 93 (1987) 1009-1013
28. Atkin W.S., Morson B.C., and Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326 (1992) 658-662
29. Muller A.D., and Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy. A case-control study of 32,702 veterans. Ann Intern Med 123 (1995) 904-910
30. Wegener M., Borsch G., and Schmidt G. Colorectal adenomas. Distribution, incidence of malignant transformation, and rate of recurrence. Dis Colon Rectum 29 (1986) 383-387
31. Gschwantler M., Kriwanek S., Langner E., Goritzer B., Schrutka-Kolbl C., et al. High-grade dysplasia and invasive carcinoma in colorectal adenomas: a multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol 14 (2002) 183-188
32. Church J.M. Clinical significance of small colorectal polyps. Dis Colon Rectum 47 (2004) 481-485
33. Butterly L.F., Chase M.P., Pohl H., and Fiarman G.S. Prevalence of clinically important histology in small adenomas. Clin Gastroenterol Hepatol 4 (2006) 343-348
34. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
35. Eide T.J. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 38 (1986) 173-176
36. Nusko G., Mansmann U., Partzsch U., Altendorf-Hofmann A., Groitl H., Wittekind C., et al. Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. Endoscopy 29 (1997) 626-631
37. Imperiale T.F., Wagner D.R., Lin C.Y., Larkin G.N., Rogge J.D., and Ransohoff D.F. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343 (2000) 169-174
38. Winawer S.J., and Zauber A.G. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am 12 (2002) 1-9
39. Hoff G., Foerster A., Vatn M.H., Sauar J., and Larsen S. Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection. Scand J Gastroenterol 21 (1986) 853-862
40. Hofstad B., Vatn M.H., Andersen S.N., Huitfeldt H.S., Rognum T., Larsen S., et al. Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut 39 (1996) 449-456
41. Goulston K.J., Cook I., and Dent O.F. How important is rectal bleeding in the diagnosis of bowel cancer and polyps?. Lancet 2 (1986) 261-265
42. Lieberman D.A., Holub J., Eisen G., Kraemer D., and Morris C.D. Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol 3 (2005) 798-805
43. Gross C.P., Andersen M.S., Krumholz H.M., McAvay G.J., Proctor D., and Tinetti M.E. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. J Am Med Assoc 296 (2006) 2815-2822
44. Ries LA, Kosary CL, Hankey BF, editors. SEER cancer statistics review, 1973-1994. Bethesda, MD: National Institutes of Health, National Cancer Institute; 1997. NIH Publication No. 97-2789.
45. Guide to Clinical Preventive Services. U.S. Preventive Services Task Force. 2nd ed. (1996), International Medical Publishing, Alexandria, VA
46. Pignone M., Saha S., Hoerger T., and Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U. S. Preventive Services Task Force. Ann Intern Med 137 (2002) 96-104
47. Hardcastle J.D., Chamberlain J.O., Robinson M.H.E., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
48. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., and Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 (1996) 1467-1471
49. Towler B., Irwig L., Glasziou P., Kewenter J., Weller D., and Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. Br Med J 317 (1998) 559-565
50. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328 (1993) 1365-1371
51. Allison J.E., Tekawa I.S., Ransom L.J., and Adrain A.L. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334 (1996) 155-159
52. Anti M., Armuzzi A., Morini S., Iascone E., Pignataro G., Coco C., et al. Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas. Gut 48 (2001) 238-246
53. Selby J.V., Friedman G.D., Quesenberry Jr. C.P., and Weiss N.S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326 (1992) 653-657
54. Newcomb P.A., Storer B.E., Morimoto L.M., Templeton A., and Potter J.D. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 95 (2003) 622-625
55. Lieberman D.A., Weiss D.G., Bond J.H., Ahnen D.J., Garewal H., and Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343 (2000) 162-168
56. Schoenfeld P., Cash B., Flood A., Dobhan R., Eastone J., Coyle W., et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 352 (2005) 2061-2068
57. Atkin W.S., Hart A., Edwards R., McIntyre P., Aubrey R., Wardle J., et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 42 (1998) 560-565
58. Kramer B.S., Gohagan J., Prorok P.C., and Smart C. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer 71 (1993) 589-593
59. Segnan N., Senore C., Andreoni B., Aste H., Bonelli L., Crosta C., et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"-SCORE. J Natl Cancer Inst 94 (2002) 1763-1772
60. Lieberman D.A., and Weiss D.G. Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345 (2001) 555-560
61. Detsky A.S. Screening for colon cancer-can we afford colonoscopy?. N Engl J Med 345 (2001) 607-608
62. Berry D.P., Clarke P., Hardcastle J.D., and Vellacott K.D. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Br J Surg 84 (1997) 1274-1276
63. Rasmussen M., Kronborg O., Fenger C., and Jorgensen O.D. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study. Scand J Gastroenterol 34 (1999) 73-78
64. Winawer S., Fletcher R., Rex D., Bond J., Burt R., Ferrucci J., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124 (2003) 544-560
65. Pignone M., Rich M., Teutsch S.M., Berg A.O., and Lohr K.N. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med 137 (2002) 132-141
66. Mori S., Ogata Y., and Shirouzu K. Biological features of sporadic colorectal carcinoma with high-frequency microsatellite instability: special reference to tumor proliferation and apoptosis. Int J Clin Oncol 9 (2004) 322-329
67. Vijan S., Inadomi J., Hayward R.A., Hofer T.P., and Fendrick A.M. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther 20 (2004) 507-515
68. Barclay R.L., Vicari J.J., Doughty A.S., Johanson J.F., and Greenlaw R.L. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 355 (2006) 2533-2541
69. Winawer S.J., Stewart E.T., Zauber A.G., Bond J.H., Ansel H., Waye J.D., et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 342 (2000) 1766-1772
70. Rex D.K., Rahmani E.Y., Haseman J.H., Lemmel G.T., Kaster S., and Buckley J.S. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 112 (1997) 17-23
71. Scheitel S.M., Ahlquist D.A., Wollan P.C., Hagen P.T., and Silverstein M.D. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy. Mayo Clin Proc 74 (1999) 1207-1213
72. Mulhall B.P., Veerappan G.R., and Jackson J.L. Meta-analysis: computed tomographic colonography. Ann Intern Med 142 (2005) 635-650
73. Halligan S., Altman D.G., Taylor S.A., Mallett S., Deeks J.J., Bartram C.I., et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 237 (2005) 893-904
74. Kim D.K., Pickhardt P.J., Taylor A.J., Leung W.K., Winter T.C., Hinshaw J.L., et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. New Engl J Med 357 (2007) 1403-1412
75. Pickhardt P.J., Choi J.R., Hwang I., Butler J.A., Puckett M.L., Hildebrandt H.A., et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349 (2003) 2191-2200
76. Cotton P.B., Durkalski V.L., Pineau B.C., Palesch Y.Y., Mauldin P.D., Hoffman B., et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. J Am Med Assoc 291 (2004) 1713-1719
77. Pickhardt P.J., Taylor A.J., Kim D.H., Reichelderfer M., Gopal D.V., and Pfau P.R. Screening for colorectal neoplasia with CT colonography: initial experience from the first year of coverage by third-party payers. Radiology 241 (2006) 417-425
78. Ahlquist D.A., Skoletsky J.E., Boynton K.A., Harrington J.J., Mahoney D.W., Pierceall W.E., et al. Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel. Gastroenterology 119 (2000) 1219-1227
79. Traverso G., Shuber A., Levin B., Johnson C., Olsson L., Schoetz Jr. D.J., et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346 (2002) 311-320
80. Winawer S.J., Zauber A.G., O'Brien M.J., Ho M.N., Gottlieb L., Sternberg S.S., et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328 (1993) 901-906
81. Martinez M.E., Sampliner R., Marshall J.R., Bhattacharyya A.K., Reid M.E., and Alberts D.S. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 120 (2001) 1077-1083
82. Noshirwani K.C., van Stolk R.U., Rybicki L.A., and Beck G.J. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 51 (2000) 433-437
83. Yang G., Zheng W., Sun Q.R., Shu X.O., Li W.D., Yu H., et al. Pathologic features of initial adenomas as predictors for metachronous adenomas of the rectum. J Natl Cancer Inst 90 (1998) 1661-1665
84. Winawer S.J., Zauber A.G., Fletcher R.H., Stillman J.S., O'Brien M.J., Levin B., et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 130 (2006) 1872-1885
85. Limburg P.J., and Ahlquist D.A. Second primary colorectal cancer: the consequence of management failure at several potential levels. Ann Intern Med 136 (2002) 335-337
86. Yamazaki T., Takii Y., Okamoto H., Sakai Y., and Hatakeyama K. What is the risk factor for metachronous colorectal carcinoma?. Dis Colon Rectum 40 (1997) 935-938
87. Togashi K., Konishi F., Ozawa A., Sato T., Shito K., Kashiwagi H., et al. Predictive factors for detecting colorectal carcinomas in surveillance colonoscopy after colorectal cancer surgery. Dis Colon Rectum 43 (2000) S47-S53
88. Nah B.K., Kim S.M., Lee Y.S., Yang H.W., Seo S.W., Sung J.K., et al. Patterns of metachronous adenoma after colorectal cancer surgery. Korean J Gastroenterol 44 (2004) 212-216
89. Kronborg O., Hage E., and Deichgraeber E. The remaining colon after radical surgery for colorectal cancer. The first three years of a prospective study. Dis Colon Rectum 26 (1983) 172-176
90. Rex D.K., Kahi C.J., Levin B., Smith R.A., Bond J.H., Brooks D., et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 130 (2006) 1865-1871
91. Hassan C., Zullo A., Winn S., Eramo A., Tomao S., Rossini F.P., et al. The colorectal malignant polyp: scoping a dilemma. Dig Liver Dis 39 (2007) 92-100
92. Gatta G., Ciccolallo L., Capocaccia R., Coleman M.P., Hakulinen T., Moller H., et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 39 (2003) 2214-2222
93. Cram P., Fendrick A.M., Inadomi J., Cowen M.E., Carpenter D., and Vijan S. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med 163 (2003) 1601-1605
94. Leard L.E., Savides T.J., and Ganiats T.G. Patient preferences for colorectal cancer screening. J Fam Pract 45 (1997) 211-218
95. Lieberman D.A., Holub J., Eisen G., Kraemer D., and Morris C.D. Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc 62 (2005) 875-883
96. Hur C., Gazelle G.S., Zalis M.E., and Podolsky D.K. An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand. Gastroenterology 127 (2004) 1312-1321
97. Ladabaum U., Song K., and Fendrick A.M. Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?. Clin Gastroenterol Hepatol 2 (2004) 554-563
98. Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention. Eur J Cancer 2000;36:1473-8.
99. Boyle P., Autier P., Bartelink H., Baselga J., Boffetta P., Burn J., et al. European Code Against Cancer and scientific justification: third version (2003). Ann Oncol 14 (2003) 973-1005